metoprolol has been researched along with MEA 2a in 2 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scholten, A | 1 |
Vriens, MR | 1 |
Cromheecke, GJ | 1 |
Borel Rinkes, IH | 1 |
Valk, GD | 1 |
Sibal, L | 1 |
Jovanovic, A | 1 |
Agarwal, SC | 1 |
Peaston, RT | 1 |
James, RA | 1 |
Lennard, TW | 1 |
Bliss, R | 1 |
Batchelor, A | 1 |
Perros, P | 1 |
2 other studies available for metoprolol and MEA 2a
Article | Year |
---|---|
Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagon | 2011 |
Phaeochromocytomas presenting as acute crises after beta blockade therapy.
Topics: Acute Disease; Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic beta-Antagonists; Adult; Cardiomyo | 2006 |